Tag Archives: psychiatric drugs

Nursing Home Abuse: Johnson & Johson Pharmaceuticals Pays 2.2 Billion Settlement As A Result Of Antipsychotic Drug Promotions

Johnson & Johnson, a pharmaceutical company has paid 2.2 billion dollars to settle claims that it improperly promoted the use of antipsychotics for nursing home residents.  As part of this settlement, Janssen, a J&J subsidiary, plead guilty to a misdemeanor criminal charge that Risperdal, an antipsychotic medication, was pushed by sales representatives for uses not […]

Nursing Home Abuse: Antipsychotics For Dementia

Daniel R. Levinson, Inspector General, U.S. Department of Health & Human Services issued his opinion on the use of antipsychotic drugs for nursing home patients. He described a new report by his office that makes clear how crucial family intervention is with nursing home patients. Families should monitor and ask questions. The report found that […]

Nursing Home Abuse: Use of Psychotropic Drugs

Psychotropic drugs are given to up to two thirds of dementia patients in nursing homes to control behavior rather than expend additional resources. A new study has found that there is an increased risk of death and other adverse outcomes when a nursing home resident is treated with conventional anti-psychotics compared with treatment with atypical […]

Nursing Homes: The “Zombie” Fear

“‘What’s people’s biggest fear?  Being a ‘zombie’ in a nursing home,” said Laurel Baxter, the Awakenings project manager.”  Awakenings is a program in place in 16 non profit nursing homes in Minnesota.  The goal of this program is wean nursing home patients off  antipsychiotic medications and  to concentrate on behavioral approaches.  A resident, who was […]

New Jersey State Psychiatric Hospitals Sued Over Forced Medication of Patients

The New York Times reported on August 4, 2010 that the group, Disability Rights New Jersey, has filed a lawsuit in the Federal District Court of NJ seeking a Court Order requiring New Jersey State psychiatric hospitals to obtain judicial review of involuntary medication. Twenty nine states have such a procedure which can involve outside panels or an advocate to represent the patient in a hearing on forced medication….